These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2404166)

  • 21. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.
    Vizcaíno I; Gadea L; Andreo L; Salas D; Ruiz-Perales F; Cuevas D; Herranz C; Bueno F;
    Radiology; 2001 May; 219(2):475-83. PubMed ID: 11323475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which breast to biopsy: an expanding dilemma.
    Lewis JD; Milbrath JR; Shaffer KA; Darin JC; DeCosse JJ
    Ann Surg; 1976 Sep; 184(3):253-7. PubMed ID: 962393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
    Chang HR; Cole B; Bland KI
    J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years.
    Osako T; Iwase T; Takahashi K; Iijima K; Miyagi Y; Nishimura S; Tada K; Makita M; Akiyama F; Sakamoto G; Kasumi F
    Breast Cancer; 2007; 14(3):255-9. PubMed ID: 17690501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-breast US imaging: four-year follow-up.
    Kopans DB; Meyer JE; Lindfors KK
    Radiology; 1985 Nov; 157(2):505-7. PubMed ID: 3901112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of breast consistency at palpation with breast density at mammography.
    Boren WL; Hunter TB; Bjelland JC; Hunt KR
    Invest Radiol; 1990 Sep; 25(9):1010-1. PubMed ID: 2211041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diaphanography in the diagnosis of breast cancer.
    Drexler B; Davis JL; Schofield G
    Radiology; 1985 Oct; 157(1):41-4. PubMed ID: 4034975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience.
    Lui CY; Lam HS; Chan LK; Tam KF; Chan CM; Leung TY; Mak KL
    Hong Kong Med J; 2007 Apr; 13(2):106-13. PubMed ID: 17406037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality assurance in excision of suspected malignant, preoperatively marked and unmarked, breast lesions. A one-year analysis].
    Leinung S; Würl P; Preusse C; Schneider JP; Börner P; Schönfelder M
    Zentralbl Chir; 2000; 125 Suppl 2():182-4. PubMed ID: 11190642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What ultrasonography can tell in breast masses that mammography and physical examination cannot.
    Rosner D; Blaird D
    J Surg Oncol; 1985 Apr; 28(4):308-13. PubMed ID: 3884906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches to the imaging, diagnosis, and biopsy of breast lesions.
    Esserman LJ
    Cancer J; 2002; 8 Suppl 1():S1-14. PubMed ID: 12075695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The detection of early breast cancer: three-year results from a diagnostic breast clinic.
    Hirst C; Furnival CM; Fielding GD; Porter AJ
    Med J Aust; 1987 Oct; 147(7):328-30. PubMed ID: 3309588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical diagnosis of early breast cancer].
    Ueno E; Tohno E; Tsunoda-Shimizu H; Aiyoshi Y; Morishima I; Ishikawa T; Fukasawa M; Yazawa T; Yashiro T
    Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():140-7. PubMed ID: 8037476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palpable presentation of breast cancer persists in the era of screening mammography.
    Mathis KL; Hoskin TL; Boughey JC; Crownhart BS; Brandt KR; Vachon CM; Grant CS; Degnim AC
    J Am Coll Surg; 2010 Mar; 210(3):314-8. PubMed ID: 20193894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic outcome of repeated mammography screening.
    Arnesson LG; Vitak B; Månson JC; Fagerberg G; Smeds S
    World J Surg; 1995; 19(3):372-7; discussion 377-8. PubMed ID: 7638991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.